Clinical Trials Logo

Clinical Trial Summary

The study is designed as a multicenter prospective trial of BTPNA for the diagnosis of peripheral pulmonary lesions in the real world. The purpose of the study is to evaluate the safety and effectiveness of BTPNA and to explore the factors of diagnosis rate.


Clinical Trial Description

The study will be conducted at about 10 clinical centers. Patients will be first screened, and only after meeting all the selection criteria, not meeting any exclusion criteria, and signing the informed consent, could they be enrolled in the group to receive BTPNA to sample the target lesions. The primary endpoint is the diagnostic yield of BTPNA. The secondary endpoints include the success rate of navigation, the operation time of the bronchoscope and so on. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04597346
Study type Observational
Source Shanghai Chest Hospital
Contact Jiayuan Sun, MD, PhD
Phone 86-021-22200000
Email xkyyjysun@163.com
Status Recruiting
Phase
Start date December 23, 2021
Completion date June 30, 2024

See also
  Status Clinical Trial Phase
Completed NCT04571476 - Diagnostic Value of UTB and TB for PPL N/A